Explore Viatris News
View Our Media Library
Explore Viatris News
Press Releases
May 16, 2022

Viatris Inc. (NASDAQ: VTRS), a global pharmaceutical company, today published its 2021 Sustainability Report, outlining the company's 2021 achievements and progress across key areas including...

May 9, 2022

First-Quarter 2022 Results Reflect Strong Operational Start to the Year Total Revenues Were $4.19 billion U.S. GAAP Net Earnings Were $399.2 million Adjusted EBITDA was $1.59 billion U.S. GAAP Net...

Apr 12, 2022

PITTSBURGH – April 12, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of its Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100),...

All Press Releases

Media Contacts

Global Communications
1000 Mylan Blvd.
Canonsburg, PA 15317

+1.724.514.1800

communications@viatris.com